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Abstract 
Our immune system consists of two types of lymphocytes; B lymphocytes which produce antibodies 
in response to an antigen, and T lymphocytes which differentiate into particular effector T 
lymphocytes such as a cytotoxic, helper or regulatory T cell in response to an antigen. Type 1 
invariant natural killer T cells (iNKT cells) are a unique population of T cells whose phenotypical, 
developmental and functional characteristics differ from conventional T cells (Novak and Lehuen, 
2011). Mitogen-Activated Protein Kinase (MAPK) signaling is critical for T lymphocyte development 
and effector responses. We define the roles of Map3k1 and Map3k7 genes in Natural Killer T (NKT) 
cells. We identify an elevated expression of the cell cycle inhibitor Cdkn1b during the Map3k1
ΔKD
 
iNKT cell clonal burst. We find aberrant Interleukin (IL) -17 production by Map3k1
ΔKD
 iNKT cells 
and altered expression of Rorc, Mmp9 and Il17rb in Map3k1
ΔKD
 iNKT cells. The liver damage seen in 
Map3k1
ΔKD 
mice could be the cause of upregulation of Il-17 and IL-1β cytokines, and IL-1β related 
genes (Il1r2 and Il1f9). Additionally we find that Map3k1
+/ΔKD 
mice injected with keyhole limpet 
hemocyanin (KLH) display a larger population of germinal center B cells compared to Map3k1
ΔKD 
mice suggesting an importance of Map3k1 in germinal center formation.  
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Abbreviations 
αGal-Cer – α-Galactoceramide 
APC – Antigen Presenting Cell  
BAFF – B-cell Activating Factor  
BCR – B Cell Receptor 
BrdU - Bromodeoxyuridine 
BSA – Bovine Serum Albumin  
C57BL/6 - C57 black 6 
Cdkn1b - Cyclin-dependent kinase inhibitor 1B 
cDNA – complementary Deoxyribonucleic Acid 
cRNA – complementary Ribonucleic Acid 
Ct – Cross threshold  
Cxcr2 - Chemokine (C-X-C motif) receptor 2 
DC – Dentritic Cell 
D-CDK4 - Cyclin-Dependent Kinase 4 
dNTP - Deoxyribonucleotide triphosphate 
EAE - Experimental Autoimmune Encephalomyelitis 
E-CDK2 - Cyclin-Dependent Kinase 2 
EDTA - Ethylenediaminetetraacetic acid 
EGr2 – Early Growth response 2 
ELISA – Enzyme Linked Immunosorbent Assay 
ERK – Extracellular Signal Regulated Kinase 
ES cell – Embryonic Stem cell  
FACS - Fluorescence-Activated Cell Sorting 
FBS – Foetal Bovine Serum 
Flp - Flippase 
FO – Follicular  
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Foxp3 - Forkhead box P3 
FRT - Flippase Recognition Target  
G1 phase – Growth 1 phase 
G2 phase – Growth 2 phase  
GM-CSF – Granulocyte Macrophage-Colony Stimulating Factor 
H&E - Hematoxylin and Eosin 
ICC – Intracellular Cytokine Staining  
IFN – Interferon  
Ig – Immunoglobulin  
iNKT – Invariant Natural Killer T  
i.p. - Intraperitoneal 
JNK – c-Jun N-terminal Kinase 
KLH – Keyhole Limpet Hemocyanin 
Lck – Lymphocyte protein tyrosine kinase 
Loxp - Locus of X-over P1 
LPS - Lipopolysaccharide 
MACS – Magnetic Activated Cell Sorting  
MAPK - Mitogen Activated Protein Kinase 
MAPKK – Mitogen Activated Protein Kinase Kinase 
MAPKKK - Mitogen Activated Protein Kinase Kinase Kinase  
MHC – Major Histocompatibility Complex 
Mmp9 - Matrix metallopeptidase 9  
mRNA – messenger Ribonucleic Acid  
MZ – Marginal Zone 
Neo - Neomycin 
NFAT - Nuclear factor of activated T-cells 
NF-κB – Nuclear Factor Kappa-light-chain-enhancer of activated B cells 
NIK - NF-κB–Inducing Kinase 
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P27 - Cyclin-dependent kinase inhibitor 1B 
PBMC – Peripheral Blood Mononuclear Cell 
PBS – Phosphate Buffer Solution  
PCR – Polymerase Chain Reaction  
PKCƟ – Protein Kinase C Ɵ 
PSG – Penicillin Streptomycin Glutamine 
qRT-PCR - quantitative Reverse Transcription Polymearase Chain Reaction 
RBC – Red Blood Cell 
RORC – RAR-Related Orphan Receptor C  
RORγ – RAR-Related Orphan Receptor Gamma 
S phase – Synthesis phase  
SAP – SLAM Associated Protein  
SAPK – Stress Activated Protein Kinase 
SEM – Standard Error of the Mean 
SLAM - Signaling Lymphocyte-Activation Molecule 
STAT3 - Signal Transducer and Activator of Transcription 3 
SV40 poly A - Simian virus 40 PolyA 
TAK1 - Transforming growth factor β activated kinase-1 
TCR – T Cell Receptor  
TD – Thymus Dependent 
TGF –Transforming Growth Factor 
Th – T helper  
TI-1 – Thymus Independent Type 1 
TI-2 – Thymus Independent Type 2 
TMB – Tetramethylbenzidine 
TNF – Tumour Necrosis Factor  
TNFR – Tumour Necrosis Factor Receptor  
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Introduction 
The cells of our immune system arise from a pluripotent hematopoietic stem cell in the bone marrow, 
which divide to produce a common lymphoid progenitor and a common myeloid progenitor. It is the 
common lymphoid progenitor that gives rise to the lymphoid lineage of leukocytes which includes 
natural killer (NK) cells and T and B cells (Fig.1). T cells mediate our adaptive immune system. An 
adaptive immune response is triggered when pathogens overcome the innate defence mechanisms. T 
cells undergo development in the thymus and once their development is complete they enter the 
bloodstream. Once they arrive at a peripheral lymphoid organ they leave the blood to migrate through 
the lymphoid tissue returning by the lymphatic system to the bloodstream to re-circulate between the 
blood and peripheral lymphoid tissues. A naive T cell is one that has not yet encountered their specific 
antigen. To participate in an adaptive immune response a naive T cell must come across its specific 
antigen, present itself as a peptide: MHC complex on the surface of an antigen presenting cell and be 
induced to proliferate and differentiate into effector T cells. CD8 T cells recognize pathogen peptides 
presented by major histocompatibilty complex (MHC) class I molecules, naive CD8 T cells 
differentiate into cytotoxic effector T cells that recognize and kill infected cells. CD4 T cells 
recognize pathogen peptides presented my MHC class II molecules. Naive CD4 T cells can 
differentiate down different pathways that produce effector subsets with different immunological 
functions. The main CD4 effector subsets are Th1 cells which activate infected macrophages and also 
provide help to B cells for antibody production, Th2 cells, which provide help to B cells for antibody 
production, especially switching to IgE and Th17 cells which enhance neutrophil response and 
promote barrier integrity (Murphy., 2011).   
iNKT cells 
Type 1 invariant natural killer T (iNKT) cells are a unique population of T cells whose phenotypical, 
developmental and functional characteristics differ from conventional T cells (Novak and Lehuen, 
2011).  iNKT cells are restricted by CD1d, a family of MHC like molecules that specialize in 
presenting lipid antigens to T cells.  iNKT cells express a highly restricted T cell receptor (TCR), a 
majority of iNKT cells express the Vα14Jα18 chains with a restricted set of β chains Vβ8.2, Vβ7 and 
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Vβ2 in mice. Type 1 NKT cells are detected with glycolipid α-galactosylceramide (α-GalCer) loaded 
CD1d tetramers. CD1d is constitutively expressed by antigen presenting cells (APCs) such as dentritic 
cells (DCs), macrophages and marginal zone (MZ) B cells. CD1d is also expressed on cortical 
thymocytes where it is necessary for NKT cell development, and on Kupffer cells and endothelial 
cells lining liver sinusoids where the highest frequency of NKT cells are found in mice (Bendelac et 
al., 2007).  iNKT cells in mice contribute approximately 0.5% of the T cell population in the blood 
and peripheral lymph nodes, 2.5% of T cells in the spleen, mesenteric and pancreatic lymph nodes and 
up to 30% of T cells in the liver (Bendelac et al., 2007). 
  
Fig 1: T cell development. The diagram shows the differentiation process that occurs to a common 
lymphoid progenitor. A common lymphoid progenitor in the bone marrow gives rise to the lymphoid 
lineage of leukocytes – the NK cells and the T and B lymphocytes.  
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iNKT cells have many functions in vivo,  during an immune response they have the ability to secrete a 
variety of cytokines within a few hours after activation such as IFN-γ, IL-4, IL-2, IL-5, IL-6, IL-10, 
IL13, Il-17, IL-21, TNF-α, TGF-β and GM-CSF with production of IL-4 and IFN-γ being  a signature 
feature of  iNKT cells following α-GalCer antigen administration. iNKT cells express high levels of 
granzyme B, perforin and FasL giving iNKT cells a cytolytic property. iNKT cells also have the 
capacity to influence other cells of the immune system. Studies have shown that iNKT cell derived 
cytokines can activate several other cell types including NK cells, conventional CD4
+
 and CD8
+ 
T 
cells, macrophages and B cells (Matsuda et al., 2008).  
Development of iNKT cells occurs in the thymus. iNKT cells diverge from conventional T cells 
during development at the double positive thymocyte stage which is concurrent with TCRβ 
expression (Matsuda et al., 2008). iNKT cell development needs the recognition of self and it has 
been shown that iNKT cells are selected at the double positive stage by CD1d expressing CD4
+
CD8
+ 
double positive thymocytes (Gapin et al., 2001). iNKT cells expand in the thymus once they have 
been positively selected. They undergo an organized maturation process that leads to the acquirement 
of their activated NK-like phenotype. Most iNKT cells leave the thymus in an immature stage 
(lacking expression of NK receptors) and complete their end maturation in the periphery (Matsuda et 
al., 2008). 
Th17 cells 
Th17 cells are a distinct lineage of pro-inflammatory T helper cells that are essential in autoimmune 
disease (Wilson et al., 2007). Th17 cells can protect the host against extracellular pathogens 
encountered at mucosal surfaces, and Th17 cells also play roles in multiple sclerosis, liver 
inflammation, inflammatory bowel disease, and psoriasis (Ouyang et al., 2008; Patel et al., 2007). 
Th17 cells secrete numerous cytokines such as IL-17A, IL-17F and IL22 (Zhou and Littman, 2009). 
IL-17 activity plays a role in acute inflammation. The IL-17 mediated release of IL-6 and IL-8 from 
mesenchymal cells leads to fever, an acute phase response (increase in levels in plasma proteins) and 
the accumulation of neutrophils in blood and tissue. IL-17 activity also contributes to chronic 
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inflammation which can be linked with matrix destruction. IL-17 induces an inhibitory effect on 
matrix production in chondrocytes and osteoblasts which leads to joint damage and defective tissue 
repair (Miossec and Kolls, 2012).   In mice, Transforming Growth Factor (TGF) -β and IL-6 cause the 
differentiation of T-cells into Th17 cells by inducing the expression of a transcription factor called 
retinoic acid receptor-related orphan nuclear receptor RORγt (encoded by Rorc) and the IL-23 
receptor (Ivanov et al., 2006; Veldhoen et al., 2006; Zhou and Littman, 2009).  
B cells 
B cells are a component of the innate and adaptive immune system. B cells posses several functions, 
they are specialized APCs that contribute to the activation/amplification of naive, activated and 
autoreactive T cell responses. B cells can produce different proinflammatory cytokines such as TNFα, 
IFNγ and IL-12 that are a feature of responses by B effector type 1 cells which are associated with 
Th1 responses. B effector type 2 cells produce IL-4 and IL-13 cytokines associated with Th2 
responses (Mauri, 2010). Both subsets make IL-2, IL-6 and IL-10 (Gray et al., 2007). B cells have the 
ability to initiate B cell proliferation, differentiation and antibody secretion to any of the three types of 
antigens – thymus independent type 1 (TI-1), thymus independent type 2 (TI-2) and thymus 
dependent (TD). B cells will go through different differentiation pathways depending on the type of 
antigen which has activated them. A B cell reacting to a TD antigen and CD40 ligand matures in the 
germinal centre and can somatically mutate and give rise to memory and plasma cells. A TI-2 
responding cell produces IgM, with no memory and little or no somatic mutation. TI-2 antigens cause 
multivalent cross linking of the B cell receptor (BCR); however there is a need for additional signals 
provided by noncognate interaction with T cells, NK cells and possibly other cell types. This leads to 
the production of IgM and some IgG3 antibodies containing few or no somatic mutations. Long term 
memory cells are not generated (Berland and Wortis, 2002). 
B cells arise from a common lymphoid progenitor and differentiate into several B cell types (Fig.2), 
such as plasma B cells, memory B cells, follicular (FO) B cells, MZ B cells, regulatory B cells, B-1 
and B-2 B cells. Plasma cells are B cells that secrete a large amount of antibodies on contact with an 
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antigen. Antibodies function both as a natural barrier to infection and as a humoral component of 
adaptive immune responses to pathogens (Bouaziz et al., 2008). Marginal zone B cells are found at 
the border of the white and red pulps of the spleen. They are able to respond rapidly to antigenic 
challenge involving metallophilic macrophages and dentritic cells. MZ B cells go through rapid 
migration to lymphoid follicles after contact with bacterial products, this helps to transport systemic 
antigens to follicular dentritic cells. MZ B cells are involved in T cell independent responses (Viau 
and Zouali, 2005). FO B cells are involved in T cell dependent antibody responses and generating 
plasma and memory cells (Viau and Zouali, 2005). B-1 B cells are a small subpopulation of B cells 
found in the pleural and peritoneal cavities, spleen and parts of the intestine. B-1 B cells are mediators 
of the innate immune system. When exposed to specific pathogens B-1 B cells are activated and 
secrete ‘natural antibodies’ which are usually of the IgM class that bind to T-cell independent antigens 
(Montecino-Rodriguez et al., 2006). B-2 (conventional) B cells are the major population of B cells 
present in the spleen and lymph nodes. They are produced in the bone marrow and function primarily 
in the adaptive immune response (Montecino-Rodriguez et al., 2006). Memory B cells occupy the 
spleen, and lymph nodes and can also be found circulating through the blood. Memory B cells are 
produced from mature B cells after their first encounter to an antigen. On subsequent exposure to the 
same antigen memory B cells respond rapidly by secreting antibodies (Murphy., 2011). Regulatory B 
cells are a phenotypically unique and rare subset of B cells. They are recognized by their CD1d
hi
CD5
+
 
phenotype and their ability to produce and secrete IL-10. Regulatory B cells have the ability to 
influence T cell activation and some inflammatory responses (Bouaziz et al., 2008).  
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MAPK signaling pathway 
MAP kinases are major components of pathways controlling embyogenesis, cell differentiation, cell 
proliferation and cell death (Pearson et al., 2001). In mammals four main groups of MAPKs have 
been found: extracellular signal regulated kinases (ERKs) 1 and 2 (ERK1/2), c-Jun amino terminal 
Fig. 2. B cell development. B cells derive from a common lymphoid progenitor cell which gives rise to 
the pro-B cell, the earliest committed B-lineage cell. B cell development begins in primary lymphoid 
tissues with maturation occurring in secondary lymphoid tissues. 
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kinases or stress activated protein kinases (JNK/SAPK) 1-3, p38MAPKα, β, γ and δ and ERK5. Most 
of the information known about these groups comes from the study of three groups of MAPKs : 
ERK1/2, JNK1/2 and p38 MAPK (Aouadi et al., 2006). MAP kinases are regulated by 
phosphorylation cascades, the phosphorylation events that comprise such cascades target the 
activation loop which is a structural feature common to all protein kinases. Phosphorylation of the 
activation loop leads to a conformational switch which enables the catalytic site to be accessible to 
ATP and protein substrates. Each MAPK family is composed of three modules activated on series and 
leading to the activation of specific MAP kinase: a MAP kinase kinase (MAPKK) represented by 
MEK or MKK proteins which phosphorylates a specific MAPK and a MAP kinase kinase kinase 
(MAPKKK) represented by Raf and MEKK proteins which phosphorylates a specific MAPK (Fig.3) 
(Aouadi et al., 2006). MEKK1 is a member of the MAPK kinase (MAP2K) kinase (MAP3K) family 
that regulate JNK and p38 MAPKS by phosphorylation of MAP2Ks activation loop (Karin and 
Gallagher, 2005; Matsuzawa et al., 2008). Map3k1
ΔKD 
B cells have intrinsic JNK and p38 signaling 
defects from Tumour Necrosis Factor (TNF) Receptor family members (TNFRs) CD40 and B cell 
activating factor belonging to the TNF family (BAFF) receptors (Matsuzawa et al., 2008). Similarly, 
another member of the MAP3K family, TGF-β Activated Kinase -1 (TAK1, encoded by Map3k7) is 
important in innate and adaptive immune signaling cascades (Ninomiya-Tsuji et al., 1999; Wang et 
al., 2001). TAK1 is activated in response to TNF family cytokines and by lipopolysaccaride (LPS), 
and is involved in controlling the activation of p38, JNK and NF-κB in several cellular systems 
(Rincon and Davis, 2009). 
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Fig 3. MAPK pathways. In mammals at least four different groups of MAPKs have been found : 
extracellular signal regulated kinases (ERKs) 1 and 2 (ERK1/2), c-Jun amino terminal kinases or stress 
activated protein kinases (JNK/SAPK) 1-3, p38MAPKα, β, γ and δ and ERK5. Most of the information 
known about these groups comes from the study of three groups of MAPKs : ERK1/2, JNK1/2 and 
p38MAPK. These serine/threonine kinases are regulated by phosphorylation cascades organized in specific 
modules. Each MAPK family is composed of three modules activated on series and leading to the 
activation of specific MAP kinase : a MAP kinase kinase (MAPKK) represented by MEK or MKK proteins 
which phosphorylates  a specific MAPK and a MAP kinase kinase kinase (MAPKKK) represented by Raf 
and MEKK proteins which phosphorylates a specific MAPKK. MAPK cascades are organized in 
complexes by scaffolding proteins that contribute to their specificity and localization.  
Abbreviations: ATF, activating transcription factor; ASK, Apoptosis Signal–regulating Kinase; DLK, dual 
leucine zipper-bearing kinase; ER, estrogen receptor; ERK, extracellular signal-regulated kinase; hsp27, 
small heat shock protein 27; JNK, c-Jun amino-terminal kinase; MAPKAP, MAP kinase-activated protein 
kinase; MEF, myocyte-enhancing factor; MEK, MAP/ERK kinase; MEKK, MEK kinase; MLK, mixed-
lineage protein kinase; Mnk, MAP kinase-interacting kinase; Msk, mitogen- and stress-activated protein 
kinase; NFAT4, Nuclear factor of activated T cells 4; PLA2, phospholipase A2; PPAR, peroxisome 
proliferative-activated receptor; Rsk, ribosomal S6 kinase; STAT, signal transducer and activator of 
transcription; TAK, transforming growth factor activated-β-protein kinase; TAO, one thousand and one 
amino acids. (Aouadi et al., 2006) 
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In this research study, we have investigated the molecular roles of Map3k1 and Map3k7 in relation to 
iNKT cells. We have shown that Map3k1 and Map3k7 differentially control iNKT cell expansion 
through distinct mechanisms. Map3k1
+/ΔKD 
and Map3k1
ΔKD
 iNKT splenic cells have been 
characterized through microarray genetic profiling to understand the molecular basis of the iNKT cell 
defect triggered by the absence of Map3ks. An increase in the cell cycle inhibitor p27 offers an 
explanation for the Map3k-dependent proliferative expansion seen in iNKT cells. An upregulated 
expression of Th17 related genes Rorc, Mmp9 and Il17rb in Map3k1
ΔKD 
iNKT cells has also been 
identified suggesting an association between the Th17 differentiation pathway and the Map3k1
ΔKD
 
iNKT cells. IL-17RB
+
 iNKT cells may also play a role in the underlying iNKT cell cytokine 
production defect present within Map3k1
ΔKD 
mice. In addition, enhanced expression of IL-17 and IL-1 
cytokines could account for the enhanced liver damage observed in Map3k1
ΔKD
mice.  
Conditional Map3k1 mice have been generated in our group using a strategy of site-specific 
recombination. In our Map3k1
flox
 mouse, a critical exon of the Map3k1 gene is flanked by FRT sites 
and loxP sites. When the Map3k1 flox mouse is crossed with Flpe mice, there will be a site-specific 
recombination at the FRT sites, creating a floxed allele. A floxed mouse is used to describe a 
genetically manipulated mouse that has a specific DNA sequence between two loxp sites. 
Recombination between loxP sites is catalysed by Cre recombinase. Floxing a gene allows it to be 
deleted (knocked out), translocated or inverted. Floxed genes can be used to produce tissue-specific 
knockouts. For example, in our case, we will be using two different Cre recombinase mice, the CD19-
Cre and Lck-cre mice that will cause the floxed Map3k1 to be inactivated in B and T cells 
respectively. If Cre expression occurs without Flp expression, a reporter knockout mouse will be 
generated which possesses a LacZ gene. Keyhole limpet hemocyanin (KLH) stimulates B cells; a 
study has shown that after 10 day immunization of Map3k1
ΔKD 
and Map3k1
+/ΔKD
 with KLH, spleens 
from Map3k1
+/ΔKD
 mice had a larger population of germinal centre B cells positive for the GL7 
marker of activated B cells compared to Map3k1
ΔKD
 mice (Gallagher et al., 2007). Stimulating B cells 
using KLH in the Map3k1 flox conditional system will allow us to investigate how silencing the 
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Map3k1 gene in B cells will influence protein signaling and the immune responses in those cells. We 
will able to assess differences in protein and cellular expression between Map3k1
flox
 and control mice.  
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Materials and Methods 
Generation of Map3k1
Δkd
 and Lck-Cre
+
Map3k7
f/f 
mice 
The research group performed experiments using the Map3k1
ΔKD 
mice. This genetically modified 
knockout Map3k1
ΔKD 
mouse strain was previously generated using a targeting vector (Fig 4) to disrupt 
the Map3k1 locus in mouse ES cells. Incorporation of the targeting vector into the Map3k1 locus leads 
to the generation of a Map3k1-β-galactosidase fusion protein containing the first 1188 amino acids of 
Map3k1 however deficient of its entire kinase domain. Homozygote double negative Map3k1 
knockout mice will be denoted as Map3k1
ΔKD 
and heterozygote single positive control Map3k1 
knockout mice will be denoted as Map3k1
+/ΔKD
 throughout the paper. Lck-Cre
+ 
and Map3k7 mice 
bought from The Jackson Laboratory, were previously crossed to generate Lck-Cre
+
Map3k7
f/f 
mice for 
ongoing research. Homozygote double negative Map3k7 knockout mice will be denoted as Lck-
Cre
+
Map3k7
f/f 
and heterozygote single positive control Map3k7 knockout mice will be denoted as 
Lck-Cre
+
Map3k7
+/f
 throughout the paper.   The mice were bred and maintained under pathogen free 
conditions in conventional barrier protection and in accordance with the guidelines of Imperial 
College London and mouse protocols approved by the Home Office (London, UK). 2μg of KRN7000 
(Enzo Life Sciences) an analogue of α-GalCer and a specific ligand for human and mouse NKT cells, 
was injected i.p. to mice that were 4 and 6 weeks old. For B cell stimulation, mice were immunized 
i.p. with 100μg KLH precipitated in alum.  
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Figure 4: Diagram of targeting strategy used to generate Map3k1
KD 
ES cells. Schematic structures of 
the Map3k1 locus, the targeting vector, and the homologous recombinant and positions of the N-terminal 
regulatory region, C-terminal catalytic kinase domain of Map3k1, restriction sites (H=HindIII; RI=EcoRI; 
P=Pstl; N=Notl;X=Xbal;B=BamHI), positive selection marker neomycin and negative selection marker 
thymidine kinase. Disruption of Map3k1 locus due to substitution of the exons coding for the Map3k1 
kinase domain with the bacterial LacZ gene, generating a Map3k1
KD
 allele which specifies the expression 
of a Map3k1 –β-galactosidase fusion protein containing the first 1188 amino acids of Map3k1 but lacking 
the kinase domain.  
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The research group have been in the process of generating Map3k1
loxP
. This was initiated by obtaining 
Map3k1
flox
 mice, maintained on a C57BL/6 background, from the Sanger Institute. A cassette was 
inserted in chromosome 13 upstream of the critical exon in Map3k1 (Fig. 5). The cassette is composed 
of an FRT site followed by a LacZ sequence and a loxP site. The first loxP site is followed by 
neomycin under the control of the human B-actin promoter, SV40 poly A, a second FRT site and a 
second loxP site. A third loxP site is inserted downstream of the targeted exon. Map3k1
+/flox
 mice 
crossed with ACTFLPe mice will cause recombination at the FRT sites, deletion of the lacZ and neo 
marker sites, and will result in offspring with a conditional Map3k1
loxP
 allele through flp recombinase 
expression. To produce mice with tissue specific Map3k1 deletion, we subsequently cross the 
Map3k1
loxP
 homozygote mice with either CD19-Cre or Lck-cre mice.  
 
 
 
 
 
Figure 5: Diagram of targeting strategy used to generate Map3k1
flox
 mice. Insertion of a cassette 
composed of an FRT site, followed by lacZ and loxP site at chromosome 13. The first loxP site is 
followed by neomycin under the control of the human β-actin promoter, SV40 polyA, a second FRT site 
and a second loxP site. A third loxP site is inserted downstream of the targeted exon. Map3k1
+/flox
 mice 
crossed with ACTFLPe mice will cause recombination at the FRT sites, deletion of the lacZ and neo 
marker sites, and will result in offspring with a conditional Map3k1
loxP
 allele through flp recombinase 
expression. Mice with deletion of Map3k1 in specific tissues will be generated following Cre-recombinase 
activity.  
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Currently this site specific recombination in Map3k1
flox
 mice is still under progress. So far the work 
done has involved crossing Map3k1
flox
 mice with FLPe mice which would cause site specific 
recombination at the FRT sites in the Map3k1
flox
 mice and the deletion of the LacZ sequence. The F1 
mice generation were biopsied and polymerase chain reaction (PCR) was carried out to check whether 
the correct genotype was obtained. Once assured that the mutant gene was present on both alleles to 
produce homozygote mice, the next step for the research group would be to cross the manipulated 
conditional Map3k1
loxP
 mice with either CD19-Cre or Lck-cre mice to silence the gene expression in 
specific tissues. 
Genotyping 
Genotyping was carried out on two strains of mice Map3k1
loxP
 and Lck-Cre
+
Map3k7 mice. For Lck-
Cre
+
Map3k7 mice, PCR was carried out for Map3k7 and Lck-Cre using appropriate primers. For the 
generation of Map3k1
loxP
 mice, PCR was carried out for Map3k1, LacZ and FLPe to ensure obtaining 
correct sized band. PCR was carried out using Extract-N-Amp Tissue PCR kit (Sigma). Water, 
Extract-N-Amp PCR reaction mix, forward primer and reverse primer and tissue extract was added to 
a total volume of 20μl. A general thermal cycling protocol (table 1) was used however adjusted 
according to different primers. 
Table 1: Common cycling parameters 
Step Temperature (ºC) Time (minutes) Cycles 
Initial denaturation 94 3 1 
Denaturation 94 0.5-1  
30-35 Annealing 45-68 0.5-1 
Extension 72 1-2 
Final extension 72 10 1 
Hold 4 Indefinitely  
 
The amplified DNA was then loaded onto an agarose gel and electrophoresis carried out to determine 
the size of bands against a DNA ladder. 
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Cell culture medium  
Most of the experiments were carried out in RPMI 1640 medium (Invitrogen), supplemented with 
10% heat-inactivated fetal bovine serum (FBS) (ThermoScientific) and 1% penicillin-streptomycin-
glutamine (PSG) (Invitrogen). 
 
Tissue preparation  
Spleens were crushed through a 70μm strainer and resuspended in RPMI medium, supplemented with 
10% FBS and 1% PSG. Spleens were then centrifuged at 1500rpm for 5 minutes. The resulting pellet 
was treated with RBC lysis buffer (Sigma), washed with PBS and resuspended in medium. Perfused 
liver was minced, pressed through a 100-µm strainer and resuspended in RPMI 1640. Liver cells were 
spun and the pellet was resuspended in 38% Percoll (GE Healthcare) and then centrifuged at 500g for 
20 min at room temperature. Cell pellets were treated with RBC lysis buffer, washed, and 
resuspended in medium. 
 
iNKT
+
 selection using CD1d selection  
The process of antibody labelled cell selection and QuadroMACS selection took place in several 
stages. First, splenocytes were surface stained with CD1d-PE (1μl of CD1d was added per 5x106 
cells), and incubated at 4ºC for 25 minutes. The cells were washed and subsequently the pellet was 
incubated with anti-PE beads (20μl per 107 cells), resuspended in 500μl of magnetic cell sorting 
(MACS) buffer (PBS with 2mM EDTA and 0.5% BSA) (Miltenyi Biotec, Surrey, United Kindom) for 
15 minutes in the dark at 4ºC. Excessive beads were washed off with 10ml of cold PBS, and the pellet 
was resuspended in 1ml of MACS buffer. Cell suspensions were run through a LS column (Miltenyi 
Biotec, Surrey, United Kingdom) placed in a magnetic field provided by the QuadroMACS. Cells 
labelled by magnetic beads remained in the column and the depleted fraction went into a collecting 
tube via flow-through solution. The LS column was then taken away from the magnetic field, washed 
twice with MACS buffer and iNKT cells were collected in the flow-through through positive 
selection, iNKT cell purity was > 95%.  
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Surface staining  
For surface staining, cells were washed twice with 1% FBS/PBS and spun. Cells were incubated for 
20 minutes at 4ºC with surface antibodies as stated in Table 1. Cells were then washed with 1% 
FBS/PBS and analyzed on Cyan ADP and further analyzed using FlowJo software (TreeStar, Inc).  
 
Intracellular cytokine staining (ICC) 
Previous to the intracellular cytokine staining stage, any surface staining was to be done was carried 
out before the fixing stage. Cells were then washed with PBS and subsequently fixed with fixation 
solution fix buffer (BD biosciences) for 20 minutes at 4ºC. Following that, cells were washed twice 
with 10x PERM buffer (BD biosciences) that allows for permeabilization of cells. This was followed 
by labelling with specific intracellular cytokine antibodies for 30 minutes at 4ºC (Table 2). A 
mastermix of antibodies was prepared in 1x PERM buffer, whenever there were several conditions to 
be stained with a similar antibody cocktail. Cells were washed with 1% FBS/PBS and resuspended in 
a small volume of PBS. Cells were analyzed on Cyan ADP and further analyzed using FlowJo 
software (TreeStar, Inc).  
Table 2. Antibodies used for surface and intracellular staining. 
 Antibody and tetramer (Clone 
number) 
Company 
Surface staining PBS-57 loaded CD1d tetramer 
 
APC-TCRβ (H57-597) 
FITC-CD3 (145-2C11) 
FITC-NK1.1 (PK136) 
FITC-CD8 (53-6.7) 
PE-Cy7-CD4 (GK1.5) 
Cxcr2-PE (LMD0410091) 
eFluor660-GL7 (E15639-103) 
PE-B220 (E01246-1632) 
Anti-IL-4 (XMG1.2) 
Anti-IFN-γ (11B11) 
National Institutes of Health 
Tetramer Facility   
eBiosciences 
eBiosciences 
eBiosciences 
eBiosciences 
eBiosciences 
R&D Systems 
eBiosciences  
eBiosciences  
eBiosciences 
eBiosciences 
ICC RORC-PE (E02046-1630) 
Phospho p38 MAPK  
Phospho STAT3 
Phospho JNK 
IL-1β-FITC (E13678-102) 
IL-17-APC (51-7177-80) 
P27 (JZA0211031) 
eBiosciences 
Cell signaling 
Cell signaling 
Cell signaling 
eBiosciences 
eBiosciences 
R&D Systems 
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Flow cytometry  
Flow cytometry was carried out on a Cyan ADP. The original gating was carried out looking at the 
forward and side scatter to get an idea of the size and the granulosity of the cells in order to pinpoint 
the lymphocyte population and to exclude dead cells. Voltage parameters were adjusted for that 
particular gating, subsequently we looked at specific lymphocyte populations such as iNKT, T cells 
and B cells by recognizing their respective markers for example CD1d for iNKT cells, CD4 for T 
cells and CD19 for B cells. From those distinct populations more surface and intracellular markers 
were gated on as listed from table 2. 
 
BrdU labelling  
For bromodeoxyuridine (BrdU) labelling, mice were fed with BrdU (0.8 mg/ml) in drinking water 
supplemented with 5% (weight/volume) glucose one day prior to α-GalCer (2μg) i.p. injection. Mice 
were treated with BrdU in drinking water for 3 days to study homeostatic proliferation. An equivalent 
starting number of cells were used in the case of Map3k1
ΔKD
 and Map3k1
+/ΔKD 
mice. They were 
surface stained and BrdU staining was performed according to the manufacturer’s protocol (BD 
Pharmingen BrdU Flow Kit). Cells were analyzed in a Cyan ADP (DakoCytomation) flow cytometer 
and further analyzed using FlowJo software (TreeStar).  
 
Enzyme-linked immune absorbent assay (ELISA) 
Blood was obtained from mice by cardiac puncture and was stored overnight at 4ºC. It was spun at 
5000g for 5 minutes and the serum was collected for ELISA. Samples were measured in triplicates on 
a 96 well plate. The 96 well plates were coated overnight at 4ºC with 100μl/well of the capture 
antibody (working concentration for IL-1β 1μg/ml) diluted in PBS. The next day the cells were 
washed three times with 0.05% Tween-20/PBS using the ELISA plate washer and blocked with 
300μl/well of assay diluent (10% FBS/PBS) for one hour at room temperature. The plates were 
washed three times before plating out the samples and standards. The maximum standard limit for IL-
1β was 2000pg/ml. The standards were prepared in assay diluent, as the samples had been in. The 
standards were plated out in duplicates 100μl/well, starting with the maximum concentration at the 
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top and diluting by a factor of 1:2 for 7 serial dilutions to reach a final concentration of zero. Samples 
were plated out 50μl/well in triplicates. After two hours incubation at room temperature, the plates 
were washed as previously described above and incubated with 100μl/well of detection antibody 
(1:500 dilution in assay diluents) diluted in assay diluent for 1 hour. The cells were washed and 
incubated with 100μl/ml of streptavidin horseradish enzyme reagent diluted 1:250 in assay diluent for 
30 minutes at room temperature . Plates were then washed six times and 100μl/well of substrate 
solution tetramethylbenzemidine (TMB) (Invitrogen) was added and incubated until the standard had 
fully developed observed from the colour change into an appropriate blue colour. Following that, 50μl 
of stop solution (2N H2SO4) was added with gentle tapping of the plate. The optical density of each 
well was measure at a wavelength of 450nm using an ELISA reader. The data was analysed using 
Excel. 
 
RNA isolation 
iNKT cell RNA was prepared using RNeasy Kit (Qiagen). The cells were washed in PBS and spun. 
350μl of RLT buffer was added for < 5x106 cells. The lysate was transferred into a QIAshredder spin 
column placed in a 2ml collection tube and spun for 2 minutes at full speed. 70% ethanol was added 
to the homogenized lysate and the sample transferred to an RNeasy spin column placed in a 2ml 
collection tube and centrifuged for 15 seconds at 8000xg. The flow through was discarded. The spin 
column was washed successively. The RNeasy spin column was placed in a new 1.5ml collection tube 
and 50μl of RNase-free water was added to the spin column membrane and spun for 1 minute at 
8000xg to elute the RNA. The RNA pellet was left to air dry and then dissolved in 30-50μl of 
nuclease free water (Bio-Rad, USA). The concentration of RNA and its quality was evaluated using 
spectrum NanoDrop (ThermoScientific, USA). A ratio of absorbance at 260nm/280nm of about 2.0 is 
generally accepted as pure for RNA. The samples were stored at -80ºC.   
 
Conversion of mRNA 
cDNA was transcribed using cDNA RT-Kit (Applied Biosystems). Following the manufacturers 
protocol, each 20μl reaction mixture contained the 10μl RNA templates (500μg mRNA), 2μl 10x RT 
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buffer, 0.8μl 25x dNTP mix, 2μl 10x random primers, 1μl reverse transcriptase, 1μl RNase inhibitor 
and 3.2μl nuclease free water. The PCR (Veriti Thermal Cycler, Applied biosystems) amplification 
programme was set to the following: 25ºC for 10 minutes, 37ºC for 120 minutes, 85ºC for 5 minutes 
and a final temperature at 4ºC. cDNA was stored at -20ºC for future use.  
 
Quantitative Reverse transcription polymearase chain reaction (qRT-PCR) 
qRT-PCR primers (Table 3) were purchased from Invitrogen. SyBr Green (Applied biosystems) was 
used as a reporter. Experiments were performed using the 384-well reaction plate (ABgene, USA). 
Each reaction contained gene-specific testing primers and SyBr green reporter namely IL-17A and 
RORC. β-actin was used as a housekeeping gene. Multiplex experiments were done in triplicates, with 
each well containing 20μl of reaction mix comprising of 5μl template cDNA, 0.3μl testing primer, 
10μl SyBr green and 4.4μl nuclease free water. The reaction plate was briefly spun to limit the 
number of bubbles. The plate was loaded onto the ABI prism 7900 HT Sequence Detection System 
(Applied Biosystems, Cheshire, UK) and the plate was run from the SDS2.1 software (Applied 
Biosystems). The thermal cycling profile was as follows 50ºC for 2 minutes, 95ºC for 15 minutes, 
then 45 cycles of amplification at 94ºC for 15 seconds and 59ºC for 30 seconds and 72ºC for 30 
seconds. The comparative method for quantification was used for analysis, since quality control and 
amplification efficiencies of the genes were equivalent Threshold Cycle (Ct) values generated were 
exported from the SDS2.1 software to Microsoft Excel for further analysis.  
 
Interpretation of qRT-PCR data 
This was a relative quantification method which did not provide information of absolute copy number 
of mRNA. Instead, it estimated the increase or decrease in target mRNA compared with β-actin 
(internal control). The main indicator used here was the Threshold Cycle (Ct) value, which was 
recorded by the device when the detecting fluorescence increased beyond an arbitrary cut off point. In 
theory, more starting material correlated with higher fluorescence hence lower Ct values. The 
different Ct values between internal and stimulation controls (∆Ct) was used to evaluate the relative 
mRNA expression level.   
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qRT-PCR was performed as described above. For every sample, there were Ct values for specific 
gene of interest (Ct gene) or β-actin (Ct beta); and the ∆Ct for each culture conditions followed the 
algorithm as the following: 
                                      ∆Ct reaction = (Ct gene – Ct beta) reaction 
Mean values were calculated for the triplicate samples. Since the ∆Ct value inversely correlated with 
the abundance of starting material, in practice, the -∆Ct reaction was more commonly used so that a 
positive value related with increased mRNA level during certain stimulation and vice versa.  
                                        Relative Quantification = 2 
-∆Ct
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Table 3. Primer sequences used for real-time PCR. 
  5' to 3' 
  Forward Primer Reverse Primer  
β-actin GTCGACAACGGCTCCGGCATGT TCCCACCATCACACCCTGGTGCCTA 
Ar TGAGCCAGGAGTGGTGTGTGC AAGTTGCGGAAGCCAGGCAAGG 
Camp AGGAACAGGGGGTGGTGAAGCA AGAAGTCCAGCCAGCCGGGAA 
Cdkn1b  GCCAGACGTAAACAGCTCCGAATTA AGAGGCAGATGGTTTAAGAGTGCCT 
CD101 AGTTTCTGCTAAGTTCAGCATCGGC TTCCTTGGTCGGGGCGCTTG 
CD177 CCTTGCTACCCTGTGTCCCAGC GGCAACCCTCGCTAACCTCGC 
CD33 GGGGAGGCAACGGTCAAGCTC CCTGCTGATGAGCCTGTGTATGGAA 
Clec4d ACCCGACATCCCCAACTGATCCC GCAGGTCCAAGTACCTCCTGTAGC 
Csf3r ACCCCATGGATGTTGCCCCC CTTCCTGCAGGGGCGTTGGC 
Cxcr2 ATCTTCGCTGTCGTCCTTGT AGCCAAGAATCTCCGTAGCA 
Il17rb GGAGGCAAGGAAGGAGCACGA CGGCCCCATCTCGGCGATTT 
Il1b CCCTGCAGCTGGAGAGTGTGGA TGTGCTCTGCTTGTGAGGTGCTG 
Il1f9 CCACAGAGTAACCCCAGTCAGCG TTCCACCTGTCCGGGTGTGGT 
Il1r2 CGGGTCAAAGGAACAACCACGGA CGGTCACACGGCCTCTTGGG 
klk1b11 CACCCACGAAATTCCAAACCCCAG CCGGCGTATTGGGTTTGCCACA 
klrc3 AGACAGTGAAGAGGAGCAGGACTTT TCTGCTGTGAGACCAGAAGCTGAC 
klrk1 TCTGCTCAGAGATGAGCAAATGCC GCCAAGGCTATAGCAAGGACTCGAA 
Mmp9 TGCCCTACCCGAGTGGACGC AGCCCAGTGCATGGCCGAAC 
Ppbp TCCTTGTTGCGCTGGCTCCC GTGTGGCTATCACTTCCACATCAGC 
Ptger1 ACATGCATGGGGTGGAGCAGC TATCAGTGGCCAAGAGGGCCAG 
Retnla CCTGCCCTGCTGGGATGACT GGGCAGTGGTCCAGTCAACGA 
Rorc TTCCCACTTCCTCAGCGCCC TGGGTGGCAGCTTGGCTAGGA 
Tdgf1 TCGCAAAGAGCACTGTGGGTC AGTGGTCGTCACAGACGGCG 
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Peripheral blood isolation 
The research group took peripheral blood from mice was obtained by cardiac puncture. One part 
blood was layered onto one part lymphocyte separation media Ficoll-Paque (GE Healthcare) and 
centrifuged for 15 minutes at 700g. PBMCs were collected from the interface layer and washed with 
sterile PBS.  
 
Microarray and bioinformatics analysis 
For microarray and bioinformatics analysis the research group took total RNA from iNKT cells and 
reverse transcribed it into biotinylated cRNA with an RNA Amplification kit as stated in the 
manufacturer’s directions (Ambion). Quality of RNA was confirmed using a 2100 Bioanalyzer 
(Agilent Technologies). Samples were hybridized to Mouse Gene 1.0 ST arrays (Affymetrix). Partek 
software was used (as stated in vendor protocols) for data analysis, quality control, and for creating 
gene lists and scatter plots. GeneSpringX software was used (as stated in vendor protocols) to produce 
heat maps. Probes with a fold change less than 2 were discarded and a list of relevant gene targets 
were selected (Table 3). Probes were quantile normalized among all microarray data. Gene lists were 
uploaded into the IPA program (Ingenuity Systems) to generate relevant signaling networks 
(according to the vendor instructions).  
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Table 3: Global changes in gene expression between Map3k1
+/KD
 and Map3k1
KD
 iNKT cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ID 
Fold 
Change Entrez Gene Name Location Type(s) 
Klrc3 2.799 
killer cell lectin-like receptor subfamily C, 
member 2 
Plasma 
Membrane other 
Ar 2.397 androgen receptor Nucleus 
ligand-dependent 
nuclear receptor 
Klrk1 2.266 
killer cell lectin-like receptor subfamily K, 
member 1 
Plasma 
Membrane 
transmembrane 
receptor 
Klk1b11 2.186 kallikrein-related peptidase 3 
Extracellular 
Space peptidase 
Cd101 -2.008 CD101 molecule 
Plasma 
Membrane other 
Cd177 -2.039 CD177 molecule Cytoplasm other 
Clec4d -2.042 C-type lectin domain family 4, member D 
Plasma 
Membrane other 
Il1r2 -2.054 interleukin 1 receptor, type II 
Plasma 
Membrane 
transmembrane 
receptor 
Rorc -2.066 RAR-related orphan receptor C Nucleus 
ligand-dependent 
nuclear receptor 
Cd33 -2.078 CD33 antigen 
Plasma 
Membrane other 
Tdgf1 -2.110 teratocarcinoma-derived growth factor 1 
Extracellular 
Space growth factor 
Il1b -2.152 interleukin 1, beta 
Extracellular 
Space cytokine 
Camp -2.230 cathelicidin antimicrobial peptide Cytoplasm other 
Csf3r -2.246 
colony stimulating factor 3 receptor 
(granulocyte) 
Plasma 
Membrane 
transmembrane 
receptor 
Cxcr2 -2.257 chemokine (C-X-C motif) receptor 2 
Plasma 
Membrane 
G-protein coupled 
receptor 
Il17rb -2.345 interleukin 17 receptor B 
Plasma 
Membrane 
transmembrane 
receptor 
Mmp9 -2.345 
matrix metallopeptidase 9 (gelatinase B, 
92kDa gelatinase, 92kDa type IV 
collagenase) 
Extracellular 
Space peptidase 
Cdkn1b -2.386 
cyclin-dependent kinase inhibitor 1B (p27, 
Kip1) Nucleus kinase 
Retnla -2.628 resistin like alpha 
Extracellular 
Space other 
Rbm39 -2.672 RNA binding motif protein 39 Nucleus 
transcription 
regulator 
Il1f9 -2.699 interleukin 36, gamma 
Extracellular 
Space cytokine 
Rapgef1 -2.914 
Rap guanine nucleotide exchange factor 
(GEF) 1 Cytoplasm other 
Ptger1 -3.025 
prostaglandin E receptor 1 (subtype EP1), 
42kDa 
Plasma 
Membrane 
G-protein coupled 
receptor 
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Liver damage assay 
The research group injected mice i.v. with 5μg KRN7000. After 3 days, the livers were harvested, 
fixed in 4% paraformaldehyde, processed and paraffin-embedded. H&E staining was carried out on 
liver sections. Slides were analyzed using an Olympus light microscope (original magnification x20) 
and pictures were taken using Image Pro-Software. 
 
Statistical analysis   
Data is expressed as SEM. Statistical significance was determined by two-tailed Student’s t-test. All 
analyses were performed using GraphPad Prism 5 software (GraphPad) and Microsoft Excel. 
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Results  
Disruption of Map3k1 and Map3k7 does not alter iNKT cell development 
To examine the role of Map3k1 and Map3k7 in iNKT development, flow cytometry analysis of the 
spleen, thymus, bone marrow and liver from Map3k1
ΔKD
, Lck-Cre
+
Map3k7
f/f 
and control mice was 
performed. There was no difference observed between the number of iNKT CD1d
+
CD3
+
 cells and no 
significant developmental defect in these organs between Map3k1
ΔKD
, Lck-Cre
+
Map3k7
f/f 
and control 
mice (Fig. 6).  
 
 
Fig 6. iNKT cell development in Map3k1
∆KD
 and Lck-Cre
+
Map3k7
f/f 
mice. 
Splenocytes, thymocytes, bone marrow and liver cells from Map3k1
ΔKD
, Map3k1
+/ΔKD
, Lck-
Cre
+
Map3k7
f/f
 and Lck-CreMap3k7
+/f  
mice were isolated and stained with CD1d tetramer and anti-
CD3 antibody and analyzed using flow cytometry as stated in the materials and methods. No observed 
difference was seen between the numbers of iNKT CD1d
+
CD3
+
 cells in Map3k1
ΔKD
, Lck-
Cre
+
Map3k7
f/f 
and control mice. Data was representative of 3 mice per group from 3 independent 
experiments.  
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The profiles of CD4
+ 
and CD8
+
 T cell subsets were analyzed in Map3k1
ΔKD
, Lck-Cre
+
Map3k7
f/f 
and no 
significant difference was found in comparison with control mice, revealing that normal lymphocyte 
development is able to occur in the absence of Map3k1 and Map3k7 without antigen stimulation (Fig. 
7). 
 
 
Fig 7. iNKT development in Map3k1
∆KD
 and Lck-Cre
+
Map3k7
f/f 
mice. 
Splenocytes, thymocytes, bone marrow and liver cells from Map3k1
+/ΔKD
, Lck-Cre
+
Map3k7
f/f
 and Lck-
CreMap3k7
+/f
  mice were isolated and stained with anti-CD4 and anti-CD8 antibodies and analyzed 
by flow cytometry. No significant difference in lymphocyte development was found in Map3k1
ΔKD
, 
and Lck-Cre
+
Map3k7
f/f 
compared with control mice. Data was representative of 3 mice per group from 
2 independent experiments. 
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Map3k1 and Map3k7 kinases differently regulate the splenic iNKT clonal burst  
To establish whether there is a role for Map3k1 kinase signaling in effector iNKT cell responses to 
glycolipid antigens, splenic iNKT cells were stimulated via i.p. injection of the α-GalCer analog 
KRN7000 into Map3k1
ΔKD
 and control mice over a period of 6 days to lead to an expansion of splenic 
iNKT cells. A peak response of iNKT cells was observed on day 3 followed by a steep decline on day 
6 to numbers of an unstimulated level (Fig. 8). Reduced numbers of iNKT cells in Map3k1
ΔKD 
mice on 
day 3 suggest a defect in iNKT expansion.  
 
 
Fig 8. iNKT cell expansion in Map3k1
ΔKD
, Map3k1
+/ΔKD
, Lck-Cre
+
Map3k7
f/f
 and Lck-CreMap3k7
+/f 
mice.  
i.p. injections of α-GalCer were administered to Map3k1ΔKD, Map3k1+/ΔKD, Lck-Cre+Map3k7f/f and 
Lck-CreMap3k7
+/f 
mice over a 6 day time period. Splenocytes were harvested at days 0, 3 and 6, 
stained with CD1d tetramer and anti-CD3 antibody and analyzed using flow cytometery. A peak 
response of iNKT cells was observed on day 3 followed by a steep decline on day 6 to numbers 
corresponding to an unstimulated level. Data was representative of 3 mice per group from 3 
independent experiments.  
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Molecular basis of the defective Map3k1
ΔKD
 iNKT clonal burst 
As it was observed that there was an iNKT cell expansion defect in Map3k1
ΔKD 
mice and enhanced 
iNKT expansion in Lck-Cre
+
Map3k7
f/f 
mice upon antigenic stimulation (Fig. 8 and 9A), we wanted to 
assess the molecular mechanisms during this effect. Day 3 isolated iNKT cell mRNA from 
Map3k1
+/ΔKD 
and Map3k1
ΔKD 
mice was processed and hybridized onto Affymetrix Mouse Gene 1.0 ST 
arrays to compare the gene expression profiles between the two groups. Affymetrix array profiling 
revealed changes in gene expression between Map3k1
+/ΔKD 
and Map3k1
ΔKD 
iNKT cells at day 3. 
Significant microarray hits with a gene expression change of higher than 2 fold between the two 
genetic groups were identified; several are involved in inflammation and immune responses (Cxcr2, 
CD101, Il1f9, Il1r2, Il1β, Rorc, Il17rb and Mmp9) and cell proliferation (Cdkn1b) (Fig. 9B and C). 
Presence of the metalloproteinase Mmp9, the transcription factor Rorc/Rorγt (Ivanov et al., 2006), and 
the IL-17 receptor family Il17rb, suggested that IL-17 and Th17 cell signaling pathways support the 
iNKT cell clonal burst defect found in Map3k1
ΔD 
mice (Gaffen, 2009). Microarray screened IL1β and 
IL1β-related genes (Il1f9 and Il1r2) show an association between Map3k-dependent iNKT gene 
expression and the p38 signaling pathway (Arana-Argaez et al., 2010; Inoue et al., 2006). JNK and 
p38 MAPK activation was reduced in Map3k1
ΔKD 
iNKT cells at day 3 relative to control (Fig. 9D). 
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Fig 9. Microarray and bioinformatics analysis of the Map3k-dependent iNKT cell expansion 
defect. 
Map3k1
+/ΔKD
, Map3k1
ΔKD
, Lck-Cre
+
Map3k7
+/f
 and Lck-Cre
+
Map3k7
f/f   mice were injected i.p. with α-
GalCer to stimulate iNKT cells over a 6 day period. Splenocytes were harvested at days 0, 3 and 6, 
processed and stained with a CD1d tetramer, anti-CD3 and anti-TCRβ antibodies and analyzed by 
flow cytometry as stated in the materials and methods. (A) Statistical analysis of iNKT expansion at 
days 0, 3 and 6. The average percentage (± SEM) of CD1d
+ 
cells from 5 independent experiments is 
shown (3 mice per experiment). The upper panel corresponds to the Map3k1 genotype (Map3k1+/∆KD 
and  Map3k1KD) and the lower panel corresponds to the Map3k7 genotype (Lck-Cre+Map3k7+/f 
and  Lck-Cre+Map3k7f/f). Differences were analyzed by two-tailed students t-test (*, p ≤ 0.05; **, p 
≤ 0.01). A peak response of iNKT cells was observed on day 3 followed by a steep decline on day 6 to 
numbers of an unstimulated level. (B) RNA was isolated from Map3k1
+/ΔKD
 and Map3k1
ΔKD
 iNKT 
cells, processed and hybridized onto Affymetrix arrays as stated in the materials and methods. 
Bioinformatics analysis was performed as stated in the materials and methods. Microarray screened 
genes with a greater than 2-fold difference between the Map3k1
+/ΔKD
 and Map3k1
ΔKD 
groups was 
shown in a scatter plot. A few genes involved in immune responses and apoptosis showed differential 
expression between the experimental and control mice. (C) A heat map comparing gene hits with a 
greater than 2-fold difference between Map3k1
+/ΔKD
 and Map3k1
ΔKD 
groups was generated. 
Map3k1
+/ΔKD
 and Map3k1
ΔKD  
iNKT microarray screens were constructed as described in the material 
and methods. Colour intensity indicates the range of upregulation (9.9) versus downregulation (6.8) 
across genes compared between the Map3k1
+/ΔKD
 and Map3k1
ΔKD
 groups. (D) iNKT splenic cells were 
isolated from 3-day  α-GalCer stimulated Map3k1KD and control mice, as stated in the materials and 
methods, and were stained with CD1d tetramer, anti-CD4, anti-phospho-JNK, and anti-phospho-p38 
antibodies, and analyzed by flow cytometry. It can be seen that JNK and p38 MAPK activation was 
reduced in Map3k1
ΔKD 
iNKT cells at day 3 relative to control. 
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Map3k1
ΔKD 
iNKT cells hypoproliferate during their clonal burst  
The reduced expression of the Map3k1
ΔKD 
iNKT cell splenic population, and enhanced Cdkn1b gene 
overexpression in Map3k1
ΔKD 
mice propose that p27 (encoded by Cdkn1b) expression is a Map3k-
dependent molecular mechanism that regulates iNKT cell proliferation, as p27 is a cell cycle inhibitor 
which binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes and 
negatively regulates cell cycle progression at G1 (Kiyokawa et al., 1996). iNKT cell proliferation in 
Map3k1
ΔKD 
mice was examined next. Map3k1
ΔKD 
and Map3k1
+/ΔKD 
mice were treated with BrdU and 
then immunized by i.p. injection of α-GalCer. Splenocytes were extracted and equal numbers of cells 
from both groups were analyzed by FACS at day 3 post immunization for BrdU incorporation. iNKT 
cells extracted from Map3k1
ΔKD 
mice hyporoliferated relative to control mice (Fig. 10A), and 
Map3k1
ΔKD
 iNKT cells incorporated approximately half the BrdU of control iNKT cells (Fig. 10B). 
The upregulation of p27 expression in Map3k1
ΔKD 
mice was confirmed by microarray gene screening 
at the mRNA level by an orthogonal real-time PCR approach (Fig. 10C, left panel) at the level of 
protein expression by Western blotting (Fig. 10D) and at the cellular level by flow cytometry (Fig. 
10E). By contrast, p27 expression was reduced in Lck-Cre
+
Map3k7
f/f 
mice, which explains the 
enhanced iNKT expansion seen in Lck-Cre
+
Map3k7
f/f 
mice (Fig. 10C, middle panel).  
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Fig 10. Hypoproliferation of iNKT cells in Map3k1
KD
 mice.  
(A) Map3k1
KD
 and Map3k1
+/KD
 mice were treated with water containing BrdU, i.p. immunized with 
α- GalCer (Day 3) or left unimmunized (Day 0). Splenocytes from Map3k1+/KD (left panels) and 
Map3k1
KD
 (right panels) were stained with CD1d tetramer, anti-BrdU and anti-CD3 antibodies. It can 
be seen that iNKT cells extracted from Map3k1
ΔKD 
mice hyporoliferated relative to control mice. (B) 
Representative results from 3 quantitated iNKT proliferation experiments were statistically analysed, 
where appropriate, by two-tailed Student’s t test (*, p ≤ 0.05) (Map3k1+/KD and Map3k1KD). It 
was observed  that Map3k1
ΔKD
 iNKT cells incorporated approximately half the BrdU of control iNKT 
cells. (C) RNA was extracted from isolated iNKT cells (Map3k1+/KD, Map3k1KD, Lck-
Cre
+
Map3k7
+/f
, Lck-Cre+Map3k7f/f), reverse transcribed, and real-time PCR performed as stated in 
the materials and methods. The average relative expression (± SEM) of Cdkn1b (p27) mRNA from 3 
independent experiments was statistically analysed, where appropriate, by two-tailed Student’s t test 
(***, p ≤ 0.001). It was observed that there was an upregulation of p27 expression in Map3k1ΔKD mice 
(left panel) while p27 expression was reduced in Lck-Cre
+
Map3k7
f/f 
mice (right panel). (D) Western 
blot analysis of p27 expression in isolated iNKT cells from Map3k1
+/KD
 and Map3k1
KD
 mice at 0, 3 
and 6 days post i.p. injection with α-GalCer. Higher protein expression of p27in Map3k1ΔKD at day 3 
was observed. (e) iNKT cells from Map3k1
KD
 and control mice were stained with anti-p27 antibody 
and FACS performed (- Map3k1
+/KD
, and - Map3k1
KD
). Higher percentage of p27 positive cells were 
observed in Map3k1
ΔKD
 compared to control mice.  
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IL-17 and Th17 cell signaling pathways play a role in an underlying defect in Map3k1
ΔKD 
iNKT 
cells  
As a subset of microarray hits were related to the IL-17 and Th17 differentiation pathways, their 
expression was confirmed using orthogonal approaches. At day 3 of the iNKT clonal burst, 
phosphorylated STAT3 which is an important transcription factor in the Th17 developmental pathway 
(Chen et al., 2006), was reduced in Map3k1
ΔKD
 iNKT cells compared to their control by flow 
cytometry and Western blot assays (Fig.11A and B). Il17rb and Rorc displayed enhanced expression 
at the mRNA level, confirming the microarray screening analysis (Fig. 11C). Flow cytometry also 
confirmed the enhanced expression of Rorc in Map3k1
ΔKD
 mice at the cellular level (Fig. 11D). As 
phosphorylated STAT3 is upstream of Rorc in the Th17 signaling pathway (Ivanov et al., 2006), it is 
notable that the expression of these two transcription factors did not correlate in iNKT cells. Rorc is 
constitutively expressed in human memory Foxp3
+
 regulatory T cells that secrete IL-17 (Ayyoub et 
al., 2009) and iNKT cells have been described as showing constitutive Rorc expression (Rachitskaya 
et al., 2008). There is no difference between Il17rb and Rorc expression in Lck-Cre
+
Map3k7
f/f
 and 
control iNKT cells (Fig. 11C). Enhanced IL-17 production was seen in Map3k1
ΔKD
 iNKT cells and 
correlated with upregulated expression of Th17 related genes from the iNKT cell microarray 
screening (Fig. 11E).  
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Fig 11. Map3k-dependent Th17 and IL-17 signaling pathways regulate iNKT cells.  
Splenic iNKT cells were isolated from Map3k1
KD
, Lck-Cre
+
Map3k7
f/f
, Lck-Cre
+
Map3k2
-/-
Map3k3
f/f
, 
and control mice following i.p. injection with α-GalCer. (A) iNKT cells from Map3k1KD and control 
mice were stained with CD1d tetramer and anti-phospho-STAT3 antibody and analyzed by flow 
cytometry. It was observed that at day 3 phosphorylated STAT3 was reduced in Map3k1ΔKD iNKT cells 
compared to their control. (B) Western blot analysis of phospho-STAT3 expression in lysed iNKT cells 
from Map3k1
+/KD
 and Map3k1
KD
 mice over a 6-day timecourse following i.p. injection with α-
GalCer. It was observed that phosphorylated STAT3 was reduced in Map3k1
ΔKD
 iNKT cells compared 
to the control cells. (C) RNA was extracted from isolated iNKT cells (Map3k1+/KD, Map3k1KD, 
Lck-Cre+Map3k7+/f, Lck-Cre+Map3k7f/fmice), reverse transcribed, and real-time PCR was 
performed. The average relative expression (± SEM) of Il17rb and Rorc mRNA from 3 independent 
experiments was statistically analysed, where appropriate, by two-tailed Student’s t test (*, p ≤ 0.05; 
***, p ≤ 0.001). It was seen that there was enhanced expression of Il17rb at the mRNA level (D) 
iNKT cells from Map3k1
KD
 and control mice (- Map3k1
+/KD
, and - Map3k1
KD
) were stained with 
anti-Rorc antibody and FACS performed. There was enhanced expression of Rorc in Map3k1
ΔKD
 mice 
at the cellular level (E) Stimulated splenocytes were stained with CD1d tetramer, and anti-IL-17 
antibodies, and flow cytometry analysis performed. There was enhanced IL-17 production in 
Map3k1
ΔKD
 iNKT cells. Data was representative of 3 independent experiments. 
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Confirmation of other hits generated from Map3k1
+/ΔKD
 and Map3k1
 ΔKD 
iNKT cell microarray 
Following the findings obtained from the gene expression profile of the iNKT microarray screening, 
real-time PCR was carried out to further compare gene expression profiles between these two 
genotypes. It was identified that there was an elevated expression of IL-1β in Map3k1ΔKD iNKT cells 
and enhanced expression of IL-1β related genes Il1r2 and Il1f9 at the molecular level. It was 
confirmed that there was an upregulation of Cxcr2, CD101, CD33, CD177 and Mmp9 genes in 
Map3k1
ΔKD 
iNKT cells (Fig. 12A). Elevated expression of IL-1β in Map3k1ΔKD iNKT cells was 
confirmed at the cellular level (Fig 12B). There was also consistently increased secretion of IL-1β in 
Map3k1
KD 
mice
 
at the protein level, as measured by ELISA from serum of Map3k1
KD 
mice (Fig. 
12C). The upregulation of Cxcr2 gene in Map3k1
ΔKD 
iNKT cells was verified at the cellular level (Fig. 
12D). 
 
.  
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Fig 12. Confirming the expression of microarray hits in Map3k1
KD
 iNKT cells 
(A) iNKT splenic cells were isolated from Map3k1
ΔKD 
and Map3k1
+/ΔKD
 mice that had been stimulated 
with α-GalCer for 3 days. RNA was extracted from iNKT cells (Map3k1+/KD and Map3k1KD) for 
CD101, Cxcr2, Il1f9, Il1r2, CD33, CD177, Mmp9 and Il1β and real-time PCR was performed. An 
upregulation of Cxcr2, CD101, CD33, CD177 and Mmp9 genes in Map3k1
ΔKD 
iNKT cells was seen. 
(B) iNKT cells were stained with CD1d tetramer, anti-CD4, and anti-IL-1β antibodies. Flow 
cytometry analysis was performed. An elevated expression of IL-1β in Map3k1ΔKD iNKT cells was 
confirmed at the cellular level. (C) ELISA was carried out on serum obtained from day 3-stimulated 
mice (Map3k1+/KD and Map3k1KD mice). IL-1β secretion was evaluated at the protein level. A 
consistently increased secretion of IL-1β in Map3k1KD mice at the protein level wass seen. (D) FACS 
analysis was performed using anti-Cxcr2 antibody in Map3k1
+/KD
 (left panel) and Map3k1
KD 
(right 
panel) iNKT cells. Cxcr2
+ 
cells were gated and analysed for CD1d expression. An upregulation of 
Cxcr2 gene in Map3k1
ΔKD 
iNKT cells was observed.  
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Role of Map3k1 in the regulation of iNKT expansion in the liver and peripheral blood 
mononuclear cells (PBMC), and liver damage in mice 
iNKT cell expansion was examined in the liver and PBMC due to the defective iNKT cell splenic 
expansion seen in Map3k1
ΔKD 
mice (Fig. 13). Map3k1
ΔKD mice immunized with α-GalCer led to an 
expansion of iNKT cells in the liver with a peak response on day 3, followed
 
by a steep decline in the 
number of iNKT cells to unstimulated levels by day 6 in the liver (Fig.13A). iNKT expansion 
increased by less than 2 fold in the Map3k1
ΔKD 
mice
 
compared to control mice. Liver tissue sections 
showed evidence of liver damage following α-GalCer stimulation at day 3. The livers of Map3k1ΔKD 
mice showed a significant increase in lymphocyte infiltration (Fig. 13B). The role of Map3ks were 
also determined in day 3 glycolipid stimulated PBMC. There were significantly reduced iNKT cell 
numbers in Map3k1
ΔKD
 PBMC compared to control mice (Fig. 13C) therefore showing Map3k1 
control iNKT cell homeostatsis and expansion in PBMC.   
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Fig 13. Map3k-dependent regulation of iNKT cell expansion within the liver and PBMC.  
Liver cells were harvested at days 0, 3 and 6 from Map3k1
+/ΔKD
 and Map3k1
ΔKD  
mice that were i.p. 
immunized with α-GalCer over a 6 day time course as stated in the material and methods. (A) Liver 
cells were stained with CD1d tetramer and anti-TCRβ antibody and analyzed by flow cytometry as 
stated in the materials and methods. An expansion of iNKT cells in the liver with a peak response on 
day 3, followed
 
by a steep decline in the number of iNKT cells to unstimulated levels by day 6 is seen. 
Data was representative of 3 mice per group from 3 independent experiments. (B) Representative 
H&E stained liver sections were prepared from unstimulated (upper panels) and 3 day α-GalCer 
stimulated (lower panels) control and Map3k1
ΔKD 
mice
 
(original magnification x40). The livers of 
Map3k1
ΔKD 
mice showed a significant increase in lymphocyte infiltration at a vessel as indicated by 
arrows. Data was representative of 3 independent experiments. (C) PBMC from 3 day α-GalCer 
stimulated Map3k1
+/ΔKD
 and Map3k1
ΔKD 
mice were stained with CD1d tetramer and anti-TCRβ 
antibody and analyzed using flow cytometry. Reduced iNKT cell numbers in Map3k1
ΔKD
 PBMC 
compared to control mice was seen. Data was representative of 3 independent experiments.  
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Role of Map3k1 in germinal center formation  
Map3k1
+/ΔKD 
and Map3k1
ΔKD
 mice were immunized with KLH over a 12 day period. Germinal center 
formation was analyzed by using Gl-7, a marker for germinal center B cells and B220 a marker for B 
cells. Spleens from Map3k1
+/ΔKD
 mice had a larger population of activated B cells positive for the 
GL7 marker compared to Map3k1
ΔKD
 mice (Fig. 14). This therefore could suggest that mice lacking 
the activity of the kinase MEKK1 have defective germinal center formation.  
                    
Fig 14. B cell stimulation in Map3k1
+/ΔKD 
mice  
i.p. injections of KLH were administered to Map3k1
ΔKD
 and Map3k1
+/ΔKD 
mice over a 12 day time 
period. Splenocytes were harvested at day 10, and stained with B cell markers GL7 and B220 and 
analyzed using flow cytometry. Spleens from Map3k1
+/ΔKD
 mice stimulated with KLH had a larger 
number of B cells positive for the GL7 marker compared to spleens from Map3k1
ΔKD 
mice stimulated 
with KLH. Data was representative of 3 mice per group. 
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IFN-γ and IL-4 production in Map3k1ΔKD and Map3k1+/ΔKD mice 
Due to the defect in germinal center formation in Map3k1
ΔKD
 mice, IFN-γ and IL-4 production was 
analyzed in Map3k1
+/ΔKD 
and Map3k1
ΔKD
 mice immunized with KLH over a 12 day period by flow 
cytometry (Fig. 15). No significant difference in the percentage of IFN-γ+ and IL-4+ from CD3+ T 
cells between Map3k1
+/ΔKD 
and Map3k1
ΔKD
 mice was observed. This could suggest that the defect in 
germinal center formation in Map3k1
ΔKD
 mice is due to a knockout of MEKK1 in B cells and not from 
a T cell defect. 
 
Fig 15. IFN-γ and IL-4 production in Map3k1ΔKD and Map3k1+/ΔKD mice 
i.p. injections of KLH were administered to Map3k1
ΔKD
 and Map3k1
+/ΔKD 
mice over a 12 day time 
period. Splenocytes were harvested at day 10, and stained with anti-CD3, anti-IFN-γ and anti-IL-4 
antibodies and analyzed using flow cytometry. No significant difference was seen in the percentage of 
IL-4 and IFN-γ positive cells produced from the CD3+ fraction by Map3k1ΔKD and Map3k1+/ΔKD mice. 
Data was representative of 3 mice per group. 
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Discussion  
In this research study, we have investigated the molecular roles of Map3k1 and Map3k7 in relation to 
iNKT cells (Fig.16). We observe that no iNKT developmental defects are present in Map3k1
ΔKD
 or 
Lck-Cre
+
Map3k7
f/f 
mice. We see that there appears to be a defect in iNKT cell expansion in 
Map3k1
ΔKD
 mice, to asses this defect, microarray genetic profiling was performed to understand the 
molecular basis of the iNKT cell defect. p27 a cell cycle inhibitor provides an explanation for the 
hypoproliferation seen in Map3k1
ΔKD
. An upregulated expression of Th17 related genes Rorc, Mmp9 
and Il17rb in Map3k1
ΔKD 
iNKT cells has also been identified suggesting an association between the 
Th17 differentiation pathway and the Map3k1
ΔKD
 iNKT cells Furthermore, enhanced expression of IL-
17 and IL-1 cytokines could account for the enhanced liver damage observed in Map3k1
ΔKD
mice. 
46 
 
 
 
Fig 16. Methodology of our research and results. Detailed schematic diagram outlining the research 
performed in this study, and the overall results.  
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It has been demonstrated that disruption of Map3k1 and Map3k7 genes does not cause a change to 
iNKT cell development. However Map3k1
ΔKD
,
 
mice that have been injected with α-GalCer, show 
reduced number of iNKT cell numbers on day 3 of a 6 day time course, giving evidence to defective 
iNKT expansion. In contrast, there is elevated iNKT expansion in Lck-Cre
+
Map3k1
f/f
 compared to 
control mice at day 3. This therefore demonstrates Map3k1 and Map3k7 regulate iNKT expansion by 
distinct mechanisms. Studies have shown that in vivo stimulation of iNKT cells with α-GalCer shows 
a disappearance of cells within 3-12 hours and reappearance 24-48 hours later. Expansion of up to 10-
fold results in a maximal number of iNKT cells on day 3 followed by a decrease in cell numbers at 
day 6-9 to the same level as before stimulation. It is thought that it is a downregulation of TCR and 
NK1.1 that is the cause if iNKT disappearance. Others report that a fall in iNKT cell number after 
stimulation is caused by apoptosis mediated by Bim and classical Fas-FasL mediated activated 
induced cell death (Ansari et al., 2010).  
MAP3Ks are associated with several signaling pathway in cell types other than iNKT cells. Map3k7 
has a role in NF-κB, p38 and JNK signaling pathways and cytokine production in a cell type specific 
manner where it is found to be a negative regulator in neutrophils, however it is an important positive 
regulator in macrophages and fibroblasts (Ajibade et al., 2012). Several signaling pathways are 
involved in the regulation and development, maturation and survival of NKT cells including 
SLAM:SAP:Fyn, calcineurin:NFAT:Egr2, NIK:RelB and PKCƟ:NF-κB pathways (Bendelac et al., 
2007; Griewank et al., 2007; Lazarevic et al., 2009; Sivakumar et al., 2003). Microarray gene 
expression and bioinformatics analysis and phosphor-MAPK FACS analysis both show that Map3k1 
plays a role in p38 MAPK signaling in iNKT cells. 
To understand the molecular basis of the Map3k1
ΔKD
 iNKT cell defect in long term expansion, 
microarray gene expression profiles between Map3k1
+/ΔKD 
and Map3k1
ΔKD 
iNKT cells have been 
compared. One of the screened hits, p27 a cell cycle inhibitor display elevated expression in 
Map3k1
ΔKD 
iNKT cells compared to Map3k1
+/ΔKD 
mice. This therefore offers an explanation for the 
iNKT cell hypoproliferation seen in Map3k1
ΔKD 
mice. p27 is an inhibitor of cyclin dependent kinase 
(CDK) involved in the regulation of the cell cycle. CDKs control cell cycle progression that are 
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activated by cyclin binding and inhibited by CDK inhibitors. CDKs regulate checkpoints that combine 
mitogenic and growth inhibitory signals, coordinating cell cycle transitions. Passage from the G1 
phase to the S phase is regulated by the activities of cyclin D1/CDK4, cyclin E/CDK2 and cyclin 
A/CDK2 complexes. Cyclin B/CDK1 regulates the G2 phase -M transition. p27 has a negative effect 
on the activities of cyclin E/CDK2 and cyclin A/CDK2, it activates cyclin D/CDK complexes. In 
proliferating cells p27 is commonly bound to cyclin D/CDKs, whereas in G1 arrested cells p27 is 
found in complexes with cyclin E/CDK2. Therefore the competition for p27 between cyclin D/CDKs 
and cyclin E/CDK2 complexes seem to be essential for cell cycle progression as cyclin D/CDKs can 
sequester p27 from the cyclone E/CDK2 complex and favour progression into the S phase (Chiarle et 
al., 2001). It is a reasonable assumption that in our Map3k1
ΔKD
 cells which have high levels of p27 
expression, p27 would be complexed with cyclin E/CDK2. This would explain the hypoproliferation 
in Map3k1
ΔKD
cells. p27 and cyclin D leads to proliferation of cells, whereas p27 and cyclin E leads to 
cell arrest.  
A second subset of screened hits from the Map3k1
ΔKD 
iNKT microarray are IL-17 and Th17 cell 
signaling genes (Rorc, IL17rb and Mmp9), and this exhibits the involvement of Map3k1 in the 
regulation of IL-17 and Th17 cell signaling. Map3k1
ΔKD 
iNKT cells overproduce IL-17 which 
correlates with the upregulated expression of Th17 related microarray hits. Rorc is downstream to 
phosphorylated STAT3 in Th17 cells; however there was downregulated expression of 
phosphorylated STAT3 in Map3k1
ΔKD 
iNKT cells which is in contradiction with the upregulated 
expression of Rorc in Map3k1
ΔKD 
iNKT cells. A possible explanation for this is that Rorc is 
constitutively expressed in NKT cells (Rachitskaya et al., 2008), and therefore phosphorylated STAT3 
is not necessary for Rorc expression under these circumstances. Rorc is essential for the development 
of secondary lymphoid tissues; it is also involved in lineage specification of uncommitted CD4
+
 T 
helper cells into Th17 cells. Map3k1:MAPK signaling is a negative regulator of constitutive Rorc 
expression in iNKT cells. A distinct IL-17 producing iNKT subset (known as iNKTH17) has recently 
been identified (Michel et al., 2007; Michel et al., 2008). 2.5% of iNKT cells in the spleen were Rorc
+
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and when stimulated with α-GalCer produced high levels of IL-17. This indicates that Rorc 
expression is an important marker for identifying IL-17 producing iNKT cells (Michel et al., 2008). 
Th17 cells play a role in the onset and progression of some forms of cell mediated autoimmunity. 
Differentiation of Th17 cells can take place in the presence of particular cytokine combinations 
including TGF-β and IL-6 or TGF-β and IL-21. Th17 cells also have the ability to upregulate the IL-
23 receptor, IL-23 is important for Th17 expansion and maintenance. RORγt is the transcriptional 
regulator if Th17 development and in its absence Th17 cells fail to develop, an overexpression of 
RORγt enhances Th17 development (Coquet et al., 2008). It has been found that iNKT cells that lack 
the NK1.1 marker secrete high concentrations of IL-17 and it has recently been demonstrated that 
NKT cells that express IL-23R secrete IL-17 following stimulation with anti-CD3 and IL-23. 
Furthermore, NKT cells can secrete IL-17 in response to the ligand α-GalCer (Mills, 2008). Rapid IL-
17 release by iNKT cells that lack NK1.1 may have important physiological consequences. Th17 cells 
are considered as being the main source of IL-17 during immune responses, Th17 cells are 
differentiated effector CD4 T cells that develop from naive CD4 T cells in the presence of cytokines 
over a matter of days. NKT cells however can produce IL-17 within three hours and are therefore an 
important primary source of this proinflammatory cytokine (Coquet et al., 2008).  
In Map3k1
ΔKD 
mice there is increased in iNKT cell infiltration in the liver and a higher amount of liver 
damage compared with Map3k1
+/ΔKD
. These observations suggest that the processes underlying iNKT 
population homeostasis and expansion in the liver are distinct. An elevated amount of circulating IL-
17 and IL-1β in Map3k1ΔKD mice can provide an explanation for the increased iNKT cell infiltration 
into the liver (Hammerich et al., 2011; Lafdil et al., 2010; Ye et al., 2011). This is supported by the 
iNKT microarray analysis in the increased expression of Th17 and IL-1β related genes (Il17rb, Rorc, 
Ilr2 and Il1f9) at the mRNA level in Map3k1
ΔKD 
iNKT cells. Both IL-17 and IL-1β have been 
previously shown to have pro-inflammatory roles in liver damage (Watarai et al., 2012). It has also 
been shown that stimulation with IL-17 induces the expression of several inflammation associated 
genes, including chemokines and C-reactive protein in primary hepatocytes (Patel et al., 2007; Sparna 
et al., 2010). Furthermore a clinical study showed that serum levels of IL-1β, IL-6, TNF-α, IFN-α and 
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C-Reactive Protein were elevated in patients with chronic liver diseases (Tilg et al., 1992). Future 
research using Map3k transgenic mice as an experimental approach will help to explain T cell-
dependent inflammatory mechanisms in the liver further. 
Further in depth research based on microarray analysis of Map3k1
ΔKD 
Th17 cells may reveal 
differentially-regulated genes that are common to both iNKT and Th17 cells, which would clarify the 
mechanisms that crosslink in those two distinct cell types. It would be interesting to study a Th17 
related disease such as experimental autoimmune encephalomyelitis (EAE), which is a murine model 
of multiple sclerosis (Piccio et al., 2013), and investigate the possible relationship between Th17 cells 
and iNKT cells at the cellular, protein and molecular levels to identify the involvement of critical 
molecules. Moreover, work carried out in Map3k1/flox-Lck-Cre will silence the Map3k1gene 
specifically in the T-cell lineage in contrast to the germline and will further identify MAPK signaling 
molecules that play a role in iNKT and Th17 development. 
There is a smaller number of activated B cells from the GL-7 marker in Map3k1
ΔKD 
mice compared to 
Map3k1
+/ΔKD
 mice suggesting that there is a defect in germinal center formation. This defect could be 
explained by the possible contribution of MEKK1 in other cell types (T cells and DC’s) to germinal 
center formation as indicated by a previous research study (Gallagher et al., 2007). However we did 
not find any obvious defect in the ability of Map3k1
ΔKD
 CD3
+
 T cells to induce production of 
cytokines IFN-γ and IL-4, we can therefore assume that mice lacking activity of MEKK1 in B cells is 
the cause of the germinal center defect. It has been previously observed that the absence of MEKK1 
catalytic activity resulted in a considerable defect in germinal center formation and the production of 
TD-antigen specific antibodies.  
This work shows preliminary results on KLH-stimulated mice. More work is required in the study of 
B cells in Map3k1/CD19-Cre mice, identifying how the effect of silencing the Map3k1 gene in B cells 
will influence MAPK signaling and pinpoint the mechanisms involved. It would be interesting to 
investigate the expression of cytokines at a cellular level between mutant and control mice. 
Conformation of cytokine expression could be carried out by ELISA by measuring protein secretion 
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levels. Furthermore, investigating how the protein expression of JNK, ERK and p38 differs in 
Map3k1
flox
 versus control mice will lead to the greater understanding of the mechanisms of MAPK 
signaling in B cells. Further research in B, T cell and iNKT cells could lead to the development of 
potential therapies in autoimmune diseases.  
Limitations 
Mechanisms in mice may be different from those taking place in humans, this may make it difficult to 
correlate the results in human subjects in order to develop efficient therapies.  
We have tried to create an artificial system that mimics as closely as possible the stimulation 
happening in the human body. However the stimulation conditions used (stimulation with α-GalCer) 
in the study to induce iNKT production may vary to some degree in a physiological context.  
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